Cargando…

Site engagement for multi-site clinical trials

Multi-site clinical trials are essential within medical practice to help drive reliable and generalizable knowledge on advancing medical treatments. Although the success of multi-site trials is significantly dependent on local clinician and site research teams, best practices for engagement of site...

Descripción completa

Detalles Bibliográficos
Autores principales: Goodlett, Dana, Hung, Anna, Feriozzi, Ashley, Lu, Hien, Bekelman, Justin E., Mullins, C. Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358177/
https://www.ncbi.nlm.nih.gov/pubmed/32685765
http://dx.doi.org/10.1016/j.conctc.2020.100608
_version_ 1783558800235560960
author Goodlett, Dana
Hung, Anna
Feriozzi, Ashley
Lu, Hien
Bekelman, Justin E.
Mullins, C. Daniel
author_facet Goodlett, Dana
Hung, Anna
Feriozzi, Ashley
Lu, Hien
Bekelman, Justin E.
Mullins, C. Daniel
author_sort Goodlett, Dana
collection PubMed
description Multi-site clinical trials are essential within medical practice to help drive reliable and generalizable knowledge on advancing medical treatments. Although the success of multi-site trials is significantly dependent on local clinician and site research teams, best practices for engagement of site teams, or “site engagement,” has not been extensively discussed. Site engagement centers on including sites in the planning and implementation of clinical trials to promote trial enrollment, compliance, and applicability to local contexts. Using a case example from the RadComp Trial, a longitudinal, multi-site clinical trial, novel site engagement practices are provided across three major research phases. In the Planning Phase, site engagement builds partnerships and commitment by active elicitation of information on site specific processes and feedback on trial design. In the Conducting Phase, sustained engagement encourages bi-directional communication and facilitates learning networks for enhanced site performance. In the Dissemination Phase, site and community partnerships are leveraged to create locally designed dissemination plans for broader scientific reach and impact. Site engagement practices discussed in this paper can be replicated or molded for application in other multi-site clinical trials.
format Online
Article
Text
id pubmed-7358177
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73581772020-07-17 Site engagement for multi-site clinical trials Goodlett, Dana Hung, Anna Feriozzi, Ashley Lu, Hien Bekelman, Justin E. Mullins, C. Daniel Contemp Clin Trials Commun Article Multi-site clinical trials are essential within medical practice to help drive reliable and generalizable knowledge on advancing medical treatments. Although the success of multi-site trials is significantly dependent on local clinician and site research teams, best practices for engagement of site teams, or “site engagement,” has not been extensively discussed. Site engagement centers on including sites in the planning and implementation of clinical trials to promote trial enrollment, compliance, and applicability to local contexts. Using a case example from the RadComp Trial, a longitudinal, multi-site clinical trial, novel site engagement practices are provided across three major research phases. In the Planning Phase, site engagement builds partnerships and commitment by active elicitation of information on site specific processes and feedback on trial design. In the Conducting Phase, sustained engagement encourages bi-directional communication and facilitates learning networks for enhanced site performance. In the Dissemination Phase, site and community partnerships are leveraged to create locally designed dissemination plans for broader scientific reach and impact. Site engagement practices discussed in this paper can be replicated or molded for application in other multi-site clinical trials. Elsevier 2020-06-29 /pmc/articles/PMC7358177/ /pubmed/32685765 http://dx.doi.org/10.1016/j.conctc.2020.100608 Text en © 2020 The Authors. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Goodlett, Dana
Hung, Anna
Feriozzi, Ashley
Lu, Hien
Bekelman, Justin E.
Mullins, C. Daniel
Site engagement for multi-site clinical trials
title Site engagement for multi-site clinical trials
title_full Site engagement for multi-site clinical trials
title_fullStr Site engagement for multi-site clinical trials
title_full_unstemmed Site engagement for multi-site clinical trials
title_short Site engagement for multi-site clinical trials
title_sort site engagement for multi-site clinical trials
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358177/
https://www.ncbi.nlm.nih.gov/pubmed/32685765
http://dx.doi.org/10.1016/j.conctc.2020.100608
work_keys_str_mv AT goodlettdana siteengagementformultisiteclinicaltrials
AT hunganna siteengagementformultisiteclinicaltrials
AT feriozziashley siteengagementformultisiteclinicaltrials
AT luhien siteengagementformultisiteclinicaltrials
AT bekelmanjustine siteengagementformultisiteclinicaltrials
AT mullinscdaniel siteengagementformultisiteclinicaltrials